Zuccagnia punctata Cav. (Fabaceae, Caesalpiniaceae) is a plant with a long history of use in Argentine traditional medicines; it belongs to a monotypic genus, and is an endemic species of Argentina. This review provides a comprehensive overview of the traditional uses, phytochemistry, pharmacological activity and toxicology of Z. punctata. A wide range of traditional uses are cited in the literature such as antibacterial, antifungal, anti-inflammatory, and antitumor, among others. Pharmacological studies to date have demonstrated significant activities that support the traditional uses of this plant. No human clinical trials had been completed up to the time of this review and no toxic effect had been detected in animals. Compounds from different chemical groups have been isolated such as phenolic compounds and essential oils. Plant extracts and phytochemicals isolated exhibit a broad range of activities, anti-inflammatory, antibacterial, antifungal, antigenotoxic, antioxidant, antiulcer, and nematicidal. The main bioactive phytochemicals in the aerial parts (leaf, stem and flower) were identified as 2´, 4´-dihydroxy-3´-methoxychalcone and 2´, 4´-dihydroxychalcone and were proposed as chemical markers. Consequently, standardized dry extracts of aerial parts of Z. puntacta could be used in herbal medicinal products. Also, they could be included in phytotherapeutic preparations such as capsules, creams, and gels, and for microencapsulation.
Botanical description: Z. punctata is a glutinous and aromatic shrub 1 to 2.5 m high ( Figure 1A) ; pseudo-paripinnate resinous leaves of 3-5 cm with subopposite leaflets (5 to 13 pairs), nanophyll with acuminate apex, rounded base and entire margin ( Figure 1B ) [2a,b] . Plants bloom from August to March and fructify from November to April [1a] . Its yellow flowers, born in erect racemes, have a funnel-shaped calyx, with 5 sepals, a corolla with 5 free petals and 10 free stamens ( Figure 1C ) [1a,b,e] . Its fruits are capsule like, indehiscent, leathery, ovoid-acute, oblique, compressed and estipitade [1a,b,e] . Both leaflet epidermal surfaces and the raquis exhibit epidermal cells with straight anticlinal walls, a thick cuticle, cyclocytic stoma, crypt-located sunken capitate glandular trichomes and non-glandular one-celled trichomes arranged on the margins (Figure 2A and B) [2a-d] . In a cross section, leaflets are iso-lateral and amphi-stomatic. The middle vein presents a collateral vascular bundle with sclerenchymatous layers at the phloem pole ( Figure 2B ). Idioblasts containing druses in the mesophyll are abundant [2b] .
Popular use of aerial parts:
Infusions and decoctions in water, as well as extracts prepared by maceration in ethanol of Z. punctata aerial parts with or without flowers or fruits have been used extensively as a traditional medicine in Argentina as a foot antiseptic and rubefacient and against bacterial and fungal infections, asthma, arthritis, rheumatism, inflammation, and tumors [3a-c] . Stems are used for the building of house roofs [1a] ; they are also used to dye leaden-colored wool [3a,b, 4a-c] , and the leaf resin was used in the ritual for mummification and preservation of dead ancestors (Institute of Anthropology, UNLaR). 
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History:
In the 19 th century, Hieronymus indicated the use of Z. punctata as an anti-rheumatic and antispasmodic [5a] . Lallemant in 1894 [5b] pointed out that healers recommended a hot bath with leaves to treat rheumatism, and a tea made from sticks in cases of flank pain or pneumonia.
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Figure 2: Photographic image of Zuccagnia punctata by scanning electron microscopy (A) and light microscopy (B). A. Leaflet surface with cyclocytic stomata and sunken capitate glandular trichomes and non-glandular one-celled trichomes arranged on the margins. B. Astra blue-safranin, general aspect of glandular (gt) and non-glandular (et) trichomes and palisade mesophyll (pm) by conventional anatomy techniques.
Aerial parts of Zuccagnia punctata
Phytochemical composition: Essential oils from the aerial parts of Z. punctata were obtained by hydro-distillation and analyzed by GC-FID, GC-MS and 13 C NMR spectroscopy. Eighty constituents, mainly oxygenated monoterpenes, were identified representing from 79.0 to 95.2% of the total oils. The main components were identified as linalool and (-)-5, 6-dehydrocamphor [2c]. Thymol and carvacrol were also identified as minor components [2c].
Z. punctata showed a high content of total phenolic compounds (168.0±15 mg GAE/g aerial parts) and flavones/flavonols (16.0 ± 1.0 mg QE/g aerial parts). Thirteen phenolic compounds were isolated from the aerial parts. The isolated compounds were identified as two chalcones, 2´,4´-dihydroxy-3´-methoxychalcone (DHMC) and 2´,4´-dihydroxychalcone (DHC) ( Figure 3) ; five flavones, 3,5,7-trihydroxyflavone (galangin), 3,5-dihydroxy-7-methoxy flavone (izalpinin), 3,5,4´-trihydroxy-7-methoxy flavone (rhamnocitrin), 3-hydroxy-7,8-dimethoxyflavone, and 3,7-dihydroxy flavone (3,7-DHF) ( Figure 3) ; four flavanones, 7-hydroxy flavanone (7-HF), 5,7-dihydroxyflavanone (pinocembrin), 5-hydroxy-7-methoxy flavanone (pinostrobin), and 7-hydroxy-8-methoxyflavanone ( Figure 3) ; and two caffeic acid derivatives, 1-methyl-3-(4´-hydroxyphenyl)-propyl caffeate and 1-methyl-3-(3´,4´-dihydroxyphenyl)-propyl caffeate [3c, 6a-f, 7a-e] . Chalcones were the main constituents of aqueous, ethanolic, methanolic and dichloromethane (DCM) extracts [6c-d, 7d-e] .
Recently, Moreno et al. [2d] reported the content of total polyphenolic compounds on Z. punctata foliar surface (177±13 µg GAE/cm 2 ). Analysis of the foliar washings revealed the presence of two major constituents, DHC and DHMC. The content of both major compounds (cm 2 of leaf) was 99.2 µg DHC and 73.4 µg DHMC/cm 2 . Histochemical analysis (fluorescence microscopy and emission scanning electron microscopy coupled with energy dispersive X-ray spectrometry) revealed on the foliar surface a high accumulation of chalcones. Consequently, the authors have proposed that these could act as a defense mechanism against UV radiation for the protection of photosynthetic tissues.
As a result of pharmacological studies, several pure chalcones isolated from different plants have been approved for clinical trials for the treatment of cancer and cardiovascular disorders or have been included as ingredients in cosmetic preparations [8a,b] . Clinical trials have shown that these compounds reached reasonable plasma concentrations and did not cause toxicity [8 b] . For their potential use, the high content of both chalcones (DHC and DHMC) quantified in Z. punctata aerial parts is very interesting. Recently, Buttasi et al. [8c] have described the variability of chalcone content in four batches of Z. punctata dry extract prepared with samples collected in the same place in different months of a year by using DCM as extraction solvent (96.4-165.4 mg chalcones/g extract) ( Table 1) .
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Figure 3: Chemical structures of isolated phenolic compounds from Z. punctata. Moreno et al. [2d] also reported the content of cuticular wax in Z. punctata leaves (88 µg/cm 2 ). In the foliar wax, the main alkane constituents, identified by GC-MS, were n-heptacosane (C27), nnonacosane (C29) and n-hentriacosane (C31). 
Pharmacological activities
Antibacterial activities: The increasing prevalence of multidrugresistant bacteria has left clinicians with fewer treatment options, often resulting in the use of more costly treatments [9a] .
For the last years, there has been a renewed interest in research on alternative antimicrobials and more targeted treatment. The first strategy, including therapies used before the advent of antibiotics, was a return to traditional remedies and medicines such as essential oils, herbal and plant extracts. Some of these alternative therapies can be administered systemically, but there are many more that can be administered topically. These new treatments may complement antibiotic therapy and help reduce the further spread and development of resistance in the future. Z. punctata is used in Argentine traditional medicine as an antiseptic [3a-c] . baumannii, P. aeruginosa, and S. maltophilia [6d] . These results clearly show that DHC is more active than the whole extract (between 25 and 250 times) ( Table 2 ).
Z. punctata extract, and three major compounds isolated from it (DHC, 7-HF and 3,7-DHF), were also active against Gram-positive bacteria, four different serotypes of Streptococcus pneumoniae with MIC values between 50 and 500 µg/mL [6f] ( Table 2) . Antibacterial activities of different quantities of Z. punctata extract, DHC, 3,7-DHF and 7-HF were also examined by using a S. pneumoniae infection model in mice. Mice were infected with 10 6 CFU of S. pneumoniae and, the following day, the products were orally administered to the infected mice. Treatment with Z. punctata extract (1 mg/mice) and 7-HF (1 mg/mice) significantly reduced the number of viable S. pneumoniae in lung (p < 0.01) while DHC and 3,7-DHF had no effect in vivo.
These results suggest that the extract's antibacterial activity on S. pneumoniae, in vivo, might be related, at least in part, to the action of 7-HF [6f]. The extract and 7-HF could be considered as antibacterial natural drugs against S. pneumoniae [6f]. Activities on human pathogenic yeasts and dermatophyte fungi: In recent years, the number of infections worldwide by Candida species and dermatophytes has increased considerably and resistance to traditional antifungal therapies is also rising. Current therapeutic options appear to be highly toxic and there are a lot of drug interactions. The lack of availability of conventional antifungal agents has encouraged the search for new alternatives such as medicinal plants traditionally used in popular medicine [10a] . Native people from Argentina northwestern have reported the use of Z. punctata as an antifungal [3a-c] Table 2) . Alvarez et al. [2c] have demonstrated that essential oils obtained from Z. punctata also show antifungal activity against the dermatophytes M. gypseum, T. rubrum and T. mentagrophytes, with MIC values between 15.6 and 125 µg/mL; the oils were not active against C. albicans, C. tropicalis, S. cerevisiae or C. neoformans. The major constituents of the oil, linalool and (-)-5,6-dehydrocamphor, were also tested against the same fungal strains. Linalool showed moderate activity against dermatophytes (MICs = 125-250 µg/ mL), but was inactive against C. albicans, C. tropicalis and C. neoformans. The other major constituent, (-)-5,6-dehydrocamphor, was also inactive up to 250 µg/mL. According to these results, the main components of the essential oil from Z. punctata would not be responsible for its anti-dermatophyte activity; the activity was attributed to minor components such as thymol and carvacrol (MIC values of 15.6-31.2 µg/mL [2c].
Consequently, the polyphenolic extract of aerial parts of Z. punctata could be used as a yeast and dermatophyte growth inhibitor, while essential oils could be considered as promising antifungal agents that inhibit dermatophyte growth.
Tangarife-Castaño et al. [10a] suggested a classification system for antifungal activity in plant derivatives based on MIC values as strong inhibitors (MIC values of < 500 µg/mL), moderate inhibitors (MIC values of 600-1500 µg/mL), and weak inhibitors (MIC values of > 1600 µg/mL). Therefore, Z. punctata polyphenolic extracts and essential oils could be considered as strong antifungal agents. [7a,11] reported the antioxidant properties and mechanisms of three structurally-related flavonoids isolated from Z. punctata, 7-HF, DHC and 3,7-DHF. The scavenging activity of DPPH and ABTS radicals by Z. punctata flavonoids in ethanol solution was dominated by a sequential proton-loss electron-transfer (SPLET) mechanism, favored by 10% of the flavonoids being deprotonated. The ABTS and DPPH radical scavenging reactivity trend was DHFDHCHF, which was correlated with the electrondonor capacity of the flavonoids (Table 3) . However, the O 2 -scavenging in aqueous buffered solution was significantly controlled by the fraction of neutral flavonoids (FOH) through concerted proton-coupled electron-transfer (PCET). In this case, the radical scavenging reactivity trend was DHCDHFHF (Table 3 ). In the case of 1 O 2 quenching in ethanol solutions, the quenching efficiency was controlled by the electron donor properties of flavonoids [7a,11] . Avila et al., [11] demonstrated that DHC and 7-HF are poor singlet molecular oxygen generators upon direct photoirradiation (near UV) where the DHMC compound does not generate any of the oxidative species. Antiulcer activity: Z. punctata is used in popular medicine as a rubefacient and anti-inflammatory. Cytoprotective effects of chalcones from Z. punctata [3c,12a] and antiulcer activity of Z. punctata extract have been reported [12b] . The methanolic and aqueous extracts (infusion) of Z. punctata, as well as DHC and DHMC isolated from them, were able to inhibit 84, 43, 63 and 25% of necrotizing gastric damage, respectively (100 mg/Kg, ip).
Anti-inflammatory activity:
Inflammatory and pathogenic conditions activate cyclooxygenase (COX) and lipoxygenase (LOX), two key enzymes in the synthesis of prostanoids and eicosonoids from poly-unsaturated fatty acids, which are involved in various inflammatory and allergic disorders [13a] . Inhibition of COX activity is the mechanism by which non-steroidal antiinflammatory drugs exert their analgesic, antipyretic, antiinflammatory, and antithrombotic effects [13b] . The effect of isolated flavonoids from Z. punctata aerial parts on COX-2 was assayed by measuring the prostaglandin (PG) production by ELISA. DHC was 14-fold more potent than HF on COX-2. The activity was dose-dependent between 4-190 μM [13c] . Various synthetic chalcones were shown to be active towards one or more inflammatory mediators [8b] . Modifications of the α, β-unsaturated ketone group were observed to cause either a decrease or loss of anti-inflammatory activity, which is consistent with its role as a Michael acceptor to nucleophilic species like gluthatione or cysteine residues on proteins. The presence of a 2'-hydroxy group produced significant anti-inflammatory effects by increasing the electrophilic properties of the α,β-unsaturated ketone group due to hydrogen bonding to the ketone moiety [8b] . Both characteristics are present in DHC. The inhibition of pro-inflammatory enzymes by DHC and its antioxidant capacity support the potential use of Z. punctata as a phytomedicine, which could be used to prevent the development of chronic inflammatory pathologies.
Effect on Caenorhabditis elegans:
Due to the appearance of drugresistant worms, new therapeutically efficient and low toxicity drugs are urgently needed. The isolated flavonoids (7-HF, 3,7-DHF and DHC) from Z. punctata aerial parts were assayed on the freeliving Caenorhabditis elegans nematode. Only DHC showed an anthelmintic effect and alteration of egg hatching and larval development processes of C. elegans. At 17 μg/mL, DHC was able to kill 50% of adult nematodes [14a] . Therefore, DHC could be proposed as a potential anthelmintic drug.
Effect on the function and expression of ABCB1/P-glycoprotein multidrug transporter (P-gp): Multidrug resistance is a significant challenge in the treatment of infectious diseases and cancer. Antitumor treatments currently in use often fail at some stage of the illness. This is because many types of cancer develop resistance to chemotherapeutic drugs, rendering them unresponsive to treatment. Several studies have been performed to analyze drug resistance mechanisms. One of the major drug resistance mechanisms in cells involves decreased uptake of water soluble drugs, including foliate antagonists, nucleoside analogs, and cisplatin, which require transporters to enter cells. This decrease can be attributed to upregulation of drug transporters, such as P-gp. These transporters can export a range of anticancer drugs from the cells, thus lowering the concentration to below the level required to provide a cytotoxic effect.
Z. punctata hydroethanolic extracts, 3,7-DHF and, to a lesser extent, DHC, were able to modulate activity and expression of the ABC membrane transporters, in particular P-gp, the best known membrane efflux pump involved in drug resistance ( Figure 4 ). P-gp is physiologically expressed in the intestine apical membrane of, liver and kidney cells [15] . The studies were performed in a human proximal tubule cell line (HK-2), and the results suggested an impact of Z. punctata extract and some of its flavonoid components on drug pharmacokinetics, which are P-gp substrates, as well as a potential role on multidrug resistance modulation [7c].
Genotoxic/antigenotoxic effect: The hydroethanolic extract of Z. punctata and DHC, the major bioactive compound isolated from it, were investigated for genotoxicity/antigenotoxicity in the in vitro Comet assay test on human hepatoma HepG2 cells. Results Zuccagnia punctata: a review Natural Product Communications Vol. 11 (11) 2016 1753 indicated that the extract of Z. punctata, under the experimental conditions tested, neither affected cell viability nor induced DNA damage, and the extract protected HepG2 cells against DNA damage induced by the direct-acting genotoxic compound (4-nitroquinoline-N-oxide). The antigenotoxic effect observed could be accounted by the presence of DHC [6e]. This genotoxicological study suggests that the Z. punctata antigenotoxic properties are of great pharmacological importance and might be beneficial for cancer prevention. 
Radicals
Toxicity studies in vivo:
The possible hepatotoxic and nephrotoxic effects of Z. punctata extract (1mg/mice) were analyzed in mice with and without streptococcal infections. In both cases, the activities of alanine transaminase (ALT) and aspartate transaminase (AST) enzymes and the levels of creatinine and urea in blood were not changed by Z. punctata extract as compared with the control values. Therefore, the report showed that intake once or twice a day of 1 mg of plant extract for seven days did not result in toxicity [6f].
Zuccagnia punctata as botanical origin of Argentine propolis: It is known that the chemical composition of propolis, the natural product made by bees collecting vegetal resin, depends mainly on the phytogeographic characteristics of the collection propolis site for its botanical origin. Z. punctata was assigned as the propolis botanical origin from Amaicha del Valle, Tucuman, Argentina [7b, .
In summary, Z. punctata aerial parts have several pharmacological activities, but to date there appears to be no published research on human clinical trials.
Galenic forms
A) Decoction (dry leaves and stems): two spoons of dry plant material in 100 mL of water. 
Flowers of Zuccagnia punctata
Chemical composition: Flowers were used either directly after harvesting or as dried material by lyophilization. Hydroethanolic extracts of flowers showed a high content of phenolic compounds (166.7 ± 15 mg GAE/g flowers), similar to that of Z. punctata aerial parts (168.0 ± 15 mg GAE/g aerial parts). The content of flavones and flavonols was higher in aerial parts (16.0 ± 1.0 mg QE/g) than in flowers (9.0 ± 0.9 mg QE/g flowers). The presence of cinnamic acid, galangin, crysin, DHC and DHMC was demonstrated by TLC, HPLC-DAD, and NMR [2d]. DHMC was the major component of flower extracts, whereas in aerial parts the major component was DHC [18] .
Pharmacological activities
Antioxidant capacity: Flower extracts exhibited ABTS •+ reducing capacity, with SC 50 values of 3.8±0.2 μg GAE/mL. In addition, flower extracts were able to protect lipids from oxidation, showing an IC 50 value of 14.7±0.2 μg GAE/mL [18] . Both identified chalcones would be responsible for antioxidant capacity as demonstrated in previous reports [7a,11] .
Anti-inflammatory capacity:
The in vitro inhibitory activity of two enzymes responsible for the biosynthesis of inflammatory mediators, cyclooxygenase (COX-2) and lipoxygenase (LOX), was used as an indicator of sample anti-inflammatory activity. The phenolic extracts obtained from Z. punctata flowers were able to inhibit COX-2 (IC 50 = 59.7 µg/mL) and LOX (IC 50 = 49.6 µg/mL) [18] .
The author reported that Jarilla flowers could be considered as a new dietary supplement that could help to prevent pathologies associated with oxidative stress, and the polyphenolic extract obtained from them could be considered as a standardized phytotherapeutic product with antioxidant and anti-inflammatory activities [18] .
Antimicrobial activity: Flower extracts were active on six Candida species, C. albicans, C. krusei, C. tropicalis, C. glabrata, C. parasilopsis and C. guilliermondii (MIC values between 60 and 120 µg GAE/mL) and on methicillin-resistant Staphylococcus aureus (MRSA) and methicillin resistant Staphylococcus coagulase negative (MRSCN) (MIC values of 250 µg GAE/mL) ( Table 2) . MIC values against Enterococcus faecalis were two-fold higher (MIC values: 500 µg GAE/mL) than those against S. aureus (Table  1) . The bioautographical assay of Z. punctata flower extract on MRSA showed that the extract has two bands with antibacterial and anti-Candida activity coincident with the Rfs of chalcones [18] .
Toxicity: Flower extracts showed no toxic effect on Artemia salina. None of the doses was mutagenic to TA98 or TA100 strains under the conditions used in this assay. This result indicates the absence of mutagens that cause base pair substitution (detected in TA100) and frame-shift (detected in TA98) mutations. The absence of mutagenicity of Z. punctata flower extract in the test against Salmonella strains indicates that DNA does not seem to be a relevant target [18] . To date there appears to be no published research on human clinical trials of flower extract.
Roots and fruits of Zuccagnia punctata
While Z. punctata aerial parts have been extensively investigated for phytochemical and pharmacological properties, less research has been undertaken on the flowers, and a single report has been found on biological activity of roots and fruits.
Root extracts in DCM and light petroleum did not exhibit any antifungal activity up to 250 µg/mL, but, in contrast, fruit extracts showed interesting antifungal activities on yeasts such as C. abicans, S. cerevisiae, and C. neoformans (MIC values 62.5-250 µg/mL) and dermatophytes such as M. gypseum, T. rubrum and T. mentagrophytes (MIC values 8-16 µg/mL), 9b, Table 2 .
Conclusions:
In this review we show a broad medicinal potential of Zuccagnia punctata extracts as antifungal, antibacterial, antioxidant, antitumor, nematicidal and anti-inflammatory products, as well as their characterization from a chemical point of view and the determination of main bioactive constituents. Z. punctata could be used as dry or liquid extracts or incorporated into other herbal preparations or as an active in pharmaceutical forms (gels, creams, microencapsulates, capsules). While progress has been made in the knowledge of this species, much has still to be done, especially in human clinical trials. 
Methodology
